UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypertension and cardiovascular risk: General aspects

Pharmacological research, 2018-03, Vol.129, p.95-99

Kjeldsen, Sverre E.

2018

Volltextzugriff (PDF)

Randomized Clinical Outcome Trials in Hypertension

Hypertension (Dallas, Tex. 1979), 2024-01, Vol.81 (1), p.17-23

2024

Volltextzugriff (PDF)

Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials

Hypertension (Dallas, Tex. 1979), 2016-05, Vol.67 (5), p.808-812

2016

Volltextzugriff (PDF)

The role of β-blockers in medical treatment

Current medical research and opinion, 2024, Vol.40 (sup1), p.1-2

2024

Volltextzugriff (PDF)

Medical Therapies for Heart Failure With Preserved Ejection Fraction

Hypertension (Dallas, Tex. 1979), 2020-01, Vol.75 (1), p.23-32

2020

Volltextzugriff (PDF)

Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trials

Blood pressure, 2023-12, Vol.32 (1), p.2226757-2226757

2023

Volltextzugriff (PDF)

Why we do not need a single independent international hypertension clinical practice guideline

Journal of hypertension, 2021-11, Vol.39 (11), p.2125-2127

2021

Volltextzugriff (PDF)

Medical Measures in Hypertensives Considered Resistant

American journal of hypertension, 2024-04, Vol.37 (5), p.307-317

2024

Volltextzugriff (PDF)

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension

Hypertension (Dallas, Tex. 1979), 2016-08, Vol.68 (2), p.297-306

2016

Volltextzugriff (PDF)

Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified

Blood pressure, 2022-12, Vol.31 (1), p.210-224

2022

Volltextzugriff (PDF)

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension

Journal of hypertension, 2021-08, Vol.39 (8), p.1522-1545

2021

Volltextzugriff (PDF)

Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH

European heart journal, 2020-04, Vol.41 (16), p.1572-1574

2020

Volltextzugriff (PDF)

Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results

Journal of hypertension, 2019-01, Vol.37 (1), p.6-8

2019

Volltextzugriff (PDF)

Key questions regarding the SYMPLICITY HTN-3 trial

The Lancet (British edition), 2023-04, Vol.401 (10385), p.1336-1337

2023

Volltextzugriff (PDF)

Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines

Hypertension (Dallas, Tex. 1979), 2022-06, Vol.79 (6), p.1153-1166

2022

Volltextzugriff (PDF)

Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime

Journal of hypertension, 2020-11, Vol.38 (11), p.2144-2145

2020

Volltextzugriff (PDF)

Are People With Masked Hypertension Adherent to Their Antihypertensive Medication?

Hypertension (Dallas, Tex. 1979), 2019-09, Vol.74 (3), p.497-498

2019

Volltextzugriff (PDF)

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

European heart journal, 2018-06, Vol.39 (24), p.2243-2251

2018

Volltextzugriff (PDF)

A 30th anniversary and a glimpse of the future

Blood pressure, 2022-12, Vol.31 (1), p.1-3

2022

Volltextzugriff (PDF)

Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice

Journal of hypertension, 2017-03, Vol.35 (3), p.471-472

2017

Volltextzugriff (PDF)

Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective

Hypertension (Dallas, Tex. 1979), 2021-08, Vol.78 (2), p.555-558

2021

Volltextzugriff (PDF)

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

The lancet oncology, 2011, Vol.12 (1), p.65-82

2011

Volltextzugriff (PDF)

How to optimize the use of diuretics in patients with heart failure?

Kardiologia polska (1957), 2023-01, Vol.81 (10), p.944-949

2023

Volltextzugriff (PDF)

Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study

Blood pressure, 2021-01, Vol.30 (1), p.51-59

2021

Volltextzugriff (PDF)

1 – 25 von 953

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(909)
Mit Volltextzugriff
(849)

Publikationsform

Artikel
(939)
Buchkapitel
(11)
Texte
(2)
Reviews
(1)

Sprache

Englisch
(874)
Norwegisch
(84)
Japanisch
(66)
Bokmål, Norwegian; Norwegian Bokmål
(44)
Spanisch
(4)
Italienisch
(3)
Dänisch
(2)
Polnisch
(2)
Deutsch
(1)
Russisch
(1)

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(558)
Life Sciences & Biomedicine
(557)
Humans
(556)
Cardiovascular System & Cardiology
(462)
Peripheral Vascular Disease
(374)
Male
(300)
Hypertension - Drug Therapy
(267)
Hypertension
(251)
Middle Aged
(223)
Female
(215)
Antihypertensive Agents - Therapeutic Use
(210)
Blood Pressure
(210)
Biological And Medical Sciences
(187)
Aged
(177)
Medical Sciences
(173)
Hypertension - Physiopathology
(150)
Risk Factors
(145)
Cardiology. Vascular System
(125)
Hypertension - Complications
(125)
Adult
(119)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hypertension and cardiovascular risk: General aspects

Randomized Clinical Outcome Trials in Hypertension

Unattended Blood Pressure Measurements in the Systolic Blood Pressure Intervention Trial: Implications for Entry and Achieved Blood Pressure Values Compared With Other Trials

The role of β-blockers in medical treatment

Medical Therapies for Heart Failure With Preserved Ejection Fraction

Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trials

Why we do not need a single independent international hypertension clinical practice guideline

Medical Measures in Hypertensives Considered Resistant

Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension

Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension

Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH

Unattended automated office vs. ambulatory blood pressure in people with high cardiovascular risk: implications for understanding the SPRINT results

Key questions regarding the SYMPLICITY HTN-3 trial

Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies

Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime

Are People With Masked Hypertension Adherent to Their Antihypertensive Medication?

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

A 30th anniversary and a glimpse of the future

Adopting Systolic Pressure Intervention Trial (SPRINT)-like office blood pressure measurements in clinical practice

Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

How to optimize the use of diuretics in patients with heart failure?

Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study

Suchergebnisse filtern